Loading the company…
Loading the company…
Families: Lumbar fusion, Cervical fusion & disc arthroplasty.
All companies · Product and company coverage
In the last ten years FDA made 22 decisions for Carbofix Orthopedics (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2020 (6). The latest was on 2026-03-16.
| Family | Decisions on record |
|---|---|
| Lumbar fusion | 16 |
| Cervical fusion & disc arthroplasty | 3 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-03-16 | 510(k) | K254045 | CarboClear® Posterior Cervical Screw System; CarboClear® Hybrid Posterior Cervical Screw System |
| 2024-11-05 | 510(k) | K243106 | CarboClear® Hybrid Pedicle Screw System |
| 2024-08-01 | 510(k) | K233793 | CarboClear® X Pedicle Screw System |
| 2024-04-25 | 510(k) | K240846 | CarboClear® Hybrid Pedicle Screw System; CarboClear® Hybrid Navigated Instruments; CarboClear® Hybrid Fenestrated Pedicle Screw System and High V+® Bone Cement; CarboClear® X Fenestrated Pedicle Screw System and High V+® Bone Cement |
In 2025, Carbofix Orthopedics reported engagement with 5 surgeons and other clinicians in the states MedaRep covers, worth $15K in consulting, speaking, meals and travel for its device products, the most in Florida ($8,917 to 4). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Florida ($8,917, 4 engaged), Massachusetts ($6,351, 1 engaged).
| 2024-03-27 | 510(k) | K233989 | CarboClear® Posterior Cervical Screw System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Carbofix Orthopedics.